News
Amyotrophic lateral sclerosis (ALS) is a devastating neurological disorder of unknown cause, in which motor nerve cells of ...
The PIPE financing included participation from an existing healthcare focused institutional investor. ProMIS anticipates the gross proceeds from the PIPE financing to be approximately $2.4 million, ...
The gross proceeds to ProMIS are expected to be approximately $0.8 million, before deducting certain offering expenses. ProMIS intends to use the net proceeds from the offering towards its further ...
The city of Covington is mourning the unexpected passing of Mayor Lance Carson, who died Saturday after a courageous battle with amyotrophic lateral sclerosis.
Golf classic raises awareness for ALS, featuring local celebrities like Al Unser Jr. and Scot Pollard. Event supports research and treatment.
The ongoing EAP that is providing ALS patients with access to MN-166 (ibudilast) outside of a clinical trial is adding more ...
CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PMN), a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies targeting toxic misfolde ...
The Global Neurodegeneration Proteomics Consortium (GNPC) has published a series of research papers detailing their efforts ...
I want to eat” popped up in Chinese characters on a computer at a public hospital in central Beijing. The words were formed ...
Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's disease, can affect the way you move, breathe, eat, and behave.
A stem-cell-based "organ-on-a-chip" model of ALS mimics early biological changes seen in the degenerative disease.
AUT00201, an oral small molecule, reduced the loss of motor neurons and eased motor symptoms in a mouse model of ALS, a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results